about
Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14A potential role for multiple tissue kallikrein serine proteases in epidermal desquamationKLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton SyndromeHuman tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progressionpiggyBac transposition reprograms fibroblasts to induced pluripotent stem cellsThe kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.In silico analysis of the human kallikrein gene 6.Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.Divergent reprogramming routes lead to alternative stem-cell states.Human tissue kallikreins: physiologic roles and applications in cancer.A survey of alternative transcripts of human tissue kallikrein genes.Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DDSimple piggyBac transposon-based mammalian cell expression system for inducible protein production.Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting.VEGF regulates local inhibitory complement proteins in the eye and kidney.MBNL proteins repress ES-cell-specific alternative splicing and reprogramming.Multifaceted role of vascular endothelial growth factor signaling in adult tissue physiology: an emerging concept with clinical implications.Aberrant Accumulation of the Diabetes Autoantigen GAD65 in Golgi Membranes in Conditions of ER Stress and AutoimmunityModeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.Highly efficient site-specific transgenesis in cancer cell lines.Induced pluripotent stem cell lines derived from equine fibroblasts.Human embryonic fibroblasts support single cell enzymatic expansion of human embryonic stem cells in xeno-free cultures.Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer.Angiopoietin-1 deficiency increases tumor metastasis in mice.Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis.Cloning of a kallikrein pseudogene.Intron retention: a common splicing event within the human kallikrein gene family.Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteinsIdentification of New Splice Variants and Differential Expression of the Human Kallikrein 10 Gene, a Candidate Cancer BiomarkerMolecular Cloning of a New Gene Which Is Differentially Expressed in Breast and Prostate CancersALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and MetastasisVEGF-A from Granuloma Macrophages Regulates Granulomatous Inflammation by a Non-angiogenic Pathway during Mycobacterial InfectionVascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venulesSynaptic proximity enables NMDAR signalling to promote brain metastasisA set of microRNAs coordinately controls tumorigenesis, invasion, and metastasisInducible Protein Production in 293 Cells Using the piggyBac Transposon System
P50
Q24316359-5A59003F-82D3-408A-A887-E996405D9561Q24324426-45B83F8D-C284-45B4-9D3C-07B4B44336F7Q27310680-39BFAB4D-5D49-45D8-BB06-F0B5F348DE8BQ28300449-265F5445-C8C3-49DF-9FBF-1D566E4EE24FQ29619409-12036E1C-B702-4349-92F2-674804E0FD10Q31138489-B9F864D0-76B5-4D80-96E1-B392D4B5A82EQ33210507-8E7712B7-F2CB-42AA-AD0F-5422D45618D4Q33623357-272126D8-4DB8-4455-BB46-CD0382AE26E1Q34042718-A21E3BB3-ECF3-4368-8430-57D437A3A630Q35802061-8AC2F562-3965-4ACA-B4F7-1669B2AD9FC1Q36118881-B44CE5F0-C6B8-4CD7-8615-FBD9CC4477DAQ36607541-E13B484A-4911-408B-8DBB-BDD4577CAD70Q36729772-B286644D-8D60-4112-85D7-120AB6621F1CQ37259285-CE68F48C-5987-4C53-B4AE-066BE5C175ABQ37545004-86E0DA3F-83D0-438B-A533-B72C235AD6B9Q37601795-43E9DD99-8511-49E6-B13F-E1E99F39DE52Q37705911-011F2FD8-34E1-4426-9F87-4EFFBEE3C3D1Q38765352-F51BFB88-31A4-4758-9A6C-328561F645CFQ38957957-419902F2-F3ED-484A-BA8E-09BE4DCEEC45Q39227915-45219635-E104-4867-8F53-3CC73A1DB9DCQ39586738-0FC7E456-329F-4DF0-BA4A-3171531CDDD0Q39829163-93CE7819-5CD9-4E36-BA11-BD62240CE3CAQ40300499-C84861EB-8E97-455D-899B-4D7E3E166488Q40516624-A9F165A1-EF0C-47CE-8233-C00CB308A407Q41363001-4FE8F0B5-13FE-4ACA-9917-19CA47917164Q41369903-482657CB-DBCB-4249-AA8E-631AF097981FQ44250414-D1385255-0D3C-49F8-AF01-66C55640AE51Q45118926-BE6BC255-8D77-4C44-ACCC-210061819FE5Q45223670-18A4C207-28E1-4132-A467-188AA9DDE035Q45267227-FF214E6D-BB28-4A62-8029-9A1787CBF421Q57941803-CFFC8482-4EA8-41EB-AF28-A13A951729C5Q57942101-219804BD-CD91-4836-B172-689B12EC50A3Q57942245-3492BEE4-262D-4081-AD2E-92ED340E2A59Q64965881-751E3742-F370-4818-B8CA-64F95A090EBDQ64965890-2F328E35-1C18-42CA-AFD9-94EC803EA307Q88231951-5F53DD41-9667-4351-9848-88D84006DB94Q90168508-8F929470-79F7-40F8-B03A-E81A9898FA9DQ91197344-5544BDEA-C091-4C51-8007-36FB1085A1F2Q91643623-F77F36CC-F5C2-4D64-853C-1421AFDA9B2E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Iacovos P Michael
@ast
Iacovos P Michael
@en
Iacovos P Michael
@es
Iacovos P Michael
@nl
Iacovos P Michael
@sl
type
label
Iacovos P Michael
@ast
Iacovos P Michael
@en
Iacovos P Michael
@es
Iacovos P Michael
@nl
Iacovos P Michael
@sl
prefLabel
Iacovos P Michael
@ast
Iacovos P Michael
@en
Iacovos P Michael
@es
Iacovos P Michael
@nl
Iacovos P Michael
@sl
P106
P31
P496
0000-0001-7674-1233